Medicilon was honored again the “Top Ten Drug Innovation Service Institutions of the Year” of the Pharmaceutical Innovation Award

Recently, the “3rd Pharmaceutical Innovation Award”, a major award that has attracted the attention of pharmaceutical industry experts, academia, and the capital market, was released.  Medicilon was honored again the “Top Ten Drug Innovation Service Institutions of the Year”.  It once again demonstrates the industry’s high recognition of Medicilon‘s technical strength, service capabilities and development potential.

The “Pharmaceutical Innovation Award” is organized by the Securities Times, aiming to promote the improvement of drug innovation capabilities by selecting outstanding drug innovation projects, outstanding companies and outstanding figures in China.  The selection expert committee conducts selection based on the “Finance – Innovative Drug Index” database, drug evaluation and other related factors.  The event attracted more than 100 pharmaceutical companies, innovative drug R&D companies, and medical service companies to participate.